XML 39 R24.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Note 2 - Acquisitions (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2016
Notes Tables |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] |
|  | Zephyrus |  |  | Cliniqa |  |  | Novus |  |  | Protein Simple |  |  | CyVek |  |  | Bionostics |  |  | PrimeGene |
Current assets |  | $ | 86 |  |  | $ | 11,926 |  |  | $ | 10,739 |  |  | $ | 19,660 |  |  | $ | 1,206 |  |  | $ | 9,605 |  |  | $ | 1,272 |
Equipment |  |  | 32 |  |  |  | 1,436 |  |  |  | 1,266 |  |  |  | 1,983 |  |  |  | 971 |  |  |  | 2,180 |  |  |  | 546 |
Other long-term assets |  |  |  |  |  |  | 58 |  |  |  | 40 |  |  |  | 554 |  |  |  | 19 |  |  |  |  |  |  |  |  |
Intangible Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
In process research and development |  |  | 7,400 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Developed technology |  |  | - |  |  |  | 18,000 |  |  |  | 5,010 |  |  |  | 39,200 |  |  |  | 20,200 |  |  |  | 14,400 |  |  |  | 2,200 |
Trade name |  |  | - |  |  |  | 1,100 |  |  |  | 5,300 |  |  |  | 36,100 |  |  |  | 100 |  |  |  | 2,700 |  |  |  | 3,000 |
Customer relationships |  |  | - |  |  |  | 27,000 |  |  |  | 14,400 |  |  |  | 101,600 |  |  |  | 600 |  |  |  | 41,000 |  |  |  | 9,100 |
Non-compete agreements |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 200 |  |  |  | - |  |  |  | 2,400 |  |  |  | 322 |
Goodwill |  |  | 6,878 |  |  |  | 42,669 |  |  |  | 28,408 |  |  |  | 134,074 |  |  |  | 91,658 |  |  |  | 56,349 |  |  |  | 5.518 |
Total assets acquired |  |  | 14,396 |  |  |  | 102,189 |  |  |  | 65,163 |  |  |  | 333,371 |  |  |  | 114,754 |  |  |  | 128,634 |  |  |  | 21,958 |
Liabilities |  |  | 54 |  |  |  | 1,508 |  |  |  | 2,166 |  |  |  | 11,644 |  |  |  | 1,965 |  |  |  | 3,007 |  |  |  | 887 |
Deferred income taxes, net |  |  | 2,812 |  |  |  | 17,793 |  |  |  | 2,875 |  |  |  | 21,674 |  |  |  | (438 | ) |  |  | 22,478 |  |  |  | 2,310 |
Net assets |  |  | 11,530 |  |  |  | 82,888 |  |  | $ | 60,122 |  |  | $ | 300,053 |  |  | $ | 113,227 |  |  | $ | 103,149 |  |  | $ | 18,761 |
Less fair-value of previous investment |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 18,300 |  |  |  | - |  |  |  | - |
Net assets acquired |  |  | 11,530 |  |  |  | 82,888 |  |  |  | 60,122 |  |  |  | 300,053 |  |  |  | 94,927 |  |  |  | 103,149 |  |  |  | 18,761 |
Cash paid, net of cash acquired |  | $ | 8,030 |  |  | $ | 82,888 |  |  | $ | 60,122 |  |  | $ | 300,053 |  |  | $ | 59,927 |  |  | $ | 103,149 |  |  | $ | 6,031 |
Note Payable |  |  | 0 |  |  |  | 0 |  |  |  | 0 |  |  |  | 0 |  |  |  | 0 |  |  |  | 0 |  |  |  | 12,730 |
Contingent consideration payable |  |  | 3,500 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 35,000 |  |  |  | - |  |  |  | - |
Net purchase price |  | $ | 11,530 |  |  | $ | 82,888 |  |  | $ | 60,122 |  |  | $ | 300,053 |  |  | $ | 94,927 |  |  | $ | 103,149 |  |  | $ | 18,761 |

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration